跳至主要内容
临床试验/JPRN-UMIN000002819
JPRN-UMIN000002819已完成未知

Efficacy and safety of Clarithromycin(CAM)/Ethambutol(EB) versus Rifampicin(RIF)/Clarithromycin(CAM)/Ethambutol(EB) in Mycobacterium avium Complex(MAC): a randomized, open-label, multicenter study - Efficacy and safety of Clarithromycin(CAM)/Ethambutol(EB) versus Rifampicin(RIF)/Clarithromycin(CAM)/Ethambutol(EB) in Mycobacterium avium Complex(MAC): a randomized, open-label, multicenter study

Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine0 个研究点目标入组 100 人开始时间: 2009年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • ECOG performance status 3-4. Patients with HIV infection. Patients with history of treatment for MAC infection. Patients with any undelying disease considered tohave a significant impact on the course of treatment in this clinical study such as progressive cancer. Patients receiving immunosuppressive drug.

研究者

发起方
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine

相似试验